Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
USD $4.5 million co-funding agreement for Parkinson’s research renewed
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce that their co-funding agreement, which supports collaborative Parkinson’s clinical trials, has been renewed for a further three years.
Inflatable 5k!
Take your 5k race to the next level! The 2025 edition of the Inflatable 5K obstacle course has got even Bigger, Bouncier and Better! Why not take part in the world’s largest inflatable 5k race with friends, family or colleagues in support of Cure Parkinson’s?...
The role of faulty cell protein in Parkinson’s
A process called m6A mRNA methylation is reduced in people with Parkinson’s. Research is underway to develop drugs that can improve this protein production process.
New biotech company focused on cell transplantation for Parkinson’s
Biotech company Ryne Bio has received a large research grant from CIRM to develop their late-stage preclinical cell transplantation procedure for Parkinson’s.
Sun Pharma shines on c-ABL
Sun Pharma have published data on their new drug vodobatinib which is a c-ABL inhibitor – c-ABL is over-active in the brains of people with Parkinson’s.